儿童非髓样甲状腺癌中临床相关的胚系变异
这项全国性回顾性队列研究纳入1970至2020年诊断的97例儿童非髓样甲状腺癌患者,行胚系全基因组测序。13/97例(13%)携带已知肿瘤易感基因的(可能)致病性胚系变异,涉及APC、BRCA2、CHEK2、DICER1、HOXB13和MITF。作者据此建议对所有儿童非髓样甲状腺癌患者进行遗传咨询。
要点
- 97例儿童非髓样甲状腺癌患者中13例(13%)携带已知肿瘤易感基因的(可能)致病性胚系变异。
- 检出变异涉及APC(n=1)、BRCA2(n=2)、CHEK2(n=4)、DICER1(n=4)、HOXB13(n=1)、MITF(n=1)。
- 作者建议对所有儿童非髓样甲状腺癌患者进行遗传咨询。
核心结论
- 已知肿瘤易感基因胚系变异患病率为13%,结合修正的个人/家族史与组织学,作者建议对所有儿童非髓样甲状腺癌患者进行遗传咨询。
- 检出的肿瘤易感综合征与第二癌症风险相关,需要对先证者进行额外监测并对高危家庭成员进行症状前基因检测。
研究设计与样本
- 全国性回顾性队列研究,在三级转诊中心开展。
- 共纳入1970年至2020年间诊断的97例儿童非髓样甲状腺癌患者,行胚系全基因组测序。
- 主要结局指标为临床相关肿瘤易感基因和既往与NMTC相关基因的变异检出率。
主要发现
- 13/97例患者(13%)携带已知肿瘤易感基因的(可能)致病性胚系变异:APC(n=1)、BRCA2(n=2)、CHEK2(n=4)、DICER1(n=4)、HOXB13(n=1)、MITF(n=1)。
- 另有1例患者诊断为Pendred综合征(SLC26A4),并在其他NMTC候选易感基因中发现9个高度关注的变异。
临床怎么用
- 作者建议对所有儿童非髓样甲状腺癌患者进行遗传咨询。
- 检出的肿瘤易感综合征与第二癌症风险相关,需要对先证者进行额外监测并对高危家庭成员进行症状前基因检测。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The underlying genetic cause of nonmedullary thyroid cancer (NMTC) in children is often unknown, hampering both predictive testing of family members and preventive clinical management. OBJECTIVE: Our objectives were to investigated the potential heritability in the largest childhood NMTC cohort that has been genotyped to date. METHODS: Nationwide retrospective cohort study in tertiary referral centers. In total, 97 patients diagnosed with pediatric NMTC between 1970 and 2020 were included in this study. Patients underwent germline whole genome sequencing. The main outcome measures were mutation detection yield in (1) clinically relevant tumor predisposition genes and (2) genes previously associated with NMTC. RESULTS: In total, 13 of 97 patients (13%) carried a germline (likely) pathogenic variant in a well-known tumor predisposition gene: APC (n = 1), BRCA2 (n = 2), CHEK2 (n = 4), DICER1 (n = 4), HOXB13 (n = 1), and MITF (n = 1). In addition, 1 patient was diagnosed with Pendred syndrome (SLC26A4) and 9 variants of high interest were found in other NMTC candidate susceptibility genes. CONCLUSION: The reported prevalence (13%) of germline variants in well-known tumor predisposing genes and the added value of a revised personal/family history and histology led us to recommend genetic counseling for all patients with childhood NMTC. The detected tumor predisposition syndromes are associated with a risk for second cancers which necessitates additional surveillance of the index patients and presymptomatic genetic testing of at risk family members.
引用
- van der Tuin K, Ruano D, Knijnenburg J, et al. Clinically Relevant Germline Variants in Children With Nonmedullary Thyroid Cancer. J Clin Endocrinol Metab. 2024. PMID: 38415346. doi:10.1210/clinem/dgae107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。